Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue

Jong-Won Ha1, Steve R Ommen, A Jamil Tajik

  • 1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Insights

Early diastolic mitral annular velocity (E') measured by tissue Doppler echocardiography effectively distinguishes constrictive pericarditis from restrictive cardiomyopathies. A specific E' cut-off value offers high accuracy for diagnosing these heart conditions.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Echocardiography

Background:

  • Differentiating constrictive pericarditis from restrictive cardiomyopathy is clinically challenging.
  • Both conditions can present with similar diastolic heart failure symptoms.
  • Accurate diagnosis is crucial for appropriate treatment and patient management.

Purpose of the Study:

  • To evaluate the diagnostic utility of early diastolic mitral annular velocity (E") using tissue Doppler echocardiography.
  • To differentiate constrictive pericarditis from primary restrictive cardiomyopathy and cardiac amyloidosis.
  • To establish a specific E" cut-off value for diagnosing constrictive pericarditis.

Main Methods:

  • Seventy-five patients were studied: 23 with constrictive pericarditis, 38 with cardiac amyloidosis, and 14 with primary restrictive cardiomyopathy.
  • Standard mitral inflow characteristics were measured.
  • Tissue Doppler echocardiography was employed to measure E" at the septal annulus.

Main Results:

  • E" velocity was significantly higher in constrictive pericarditis patients (12.3 cm/s) compared to restrictive cardiomyopathy (5.1 cm/s) and cardiac amyloidosis patients.
  • An E" cut-off value of >=8 cm/s demonstrated 95% sensitivity and 96% specificity for constrictive pericarditis.
  • E" values showed no overlap between constrictive pericarditis and cardiac amyloidosis, and were lower in cardiac amyloidosis than primary restrictive cardiomyopathy.

Conclusions:

  • Early diastolic mitral annular velocity (E") is a valuable parameter for distinguishing constrictive pericarditis from restrictive cardiomyopathies.
  • A specific E" cut-off value can reliably diagnose constrictive pericarditis in patients with diastolic heart failure.
  • Tissue Doppler echocardiography provides a non-invasive method to differentiate these cardiac conditions.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...